Patient Preference Survey for Radiation Oncologists
Limited data exists for the cancer patients' preferences on their patient-doctor interaction with their radiation oncologist. These physicians have the opportunity to develop intimate relationships with their patients since these patients typically require daily radiation treatments anywhere from one to seven weeks. Thus, by having a greater understanding of the individual patient preferences, the radiation oncologists will be able to better serve their patients leading to improved patient satisfaction with their physician and healthier outlook on life. This is the premise and the hypothesis of this study.
Checked against the public recordLast updated Jul 25, 2017 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Other
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- University of Pittsburgh
- Interventions being studied
- Behavioral: Physician behavior related to Patient Preference Survey; Other: Patient Preference Results
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria:Any Patient/subject (adult male or female) with prostate or breast or lung cancer (Primary or Metastatic) who is scheduled to receive radiation therapy at one of the UPMC Cancer Centers * Patient/subject must receive radiation treatment in addition to consultation with the Radiation Oncologist * Patient/subject must meet with radiation oncologist at least one day per week while receiving radiation therapy. * Any attending radiation oncologist whose patient is enrolled in this study Exclusion Criteria: * Patient/subject under age 18 If subject previously underwent this study, even if the previous study was for a different diagnosis. Subjects can only undergo this study once. Patients/subjects who do not have the functional and mental capacity to independently answer the questionnaire.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- UPMC Cancer CentersPittsburgh, Pennsylvania
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 25, 2017. Always confirm current availability with the study team.